Spero Therapeutics (SPRO) Leases (2019 - 2025)
Historic Leases for Spero Therapeutics (SPRO) over the last 7 years, with Q3 2025 value amounting to $1.7 million.
- Spero Therapeutics' Leases fell 4971.9% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 4971.9%. This contributed to the annual value of $3.1 million for FY2024, which is 2505.42% down from last year.
- Per Spero Therapeutics' latest filing, its Leases stood at $1.7 million for Q3 2025, which was down 4971.9% from $2.6 million recorded in Q2 2025.
- Spero Therapeutics' Leases' 5-year high stood at $6.9 million during Q1 2021, with a 5-year trough of $1.7 million in Q3 2025.
- In the last 5 years, Spero Therapeutics' Leases had a median value of $4.6 million in 2023 and averaged $4.6 million.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 4512.07% in 2021, then crashed by 4971.9% in 2025.
- Spero Therapeutics' Leases (Quarter) stood at $6.5 million in 2021, then dropped by 21.53% to $5.1 million in 2022, then fell by 18.91% to $4.2 million in 2023, then decreased by 25.05% to $3.1 million in 2024, then plummeted by 45.41% to $1.7 million in 2025.
- Its Leases was $1.7 million in Q3 2025, compared to $2.6 million in Q2 2025 and $2.8 million in Q1 2025.